Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
about
Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysisDistribution and epidemiological characteristics of published individual patient data meta-analyses.Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis.Diabetes: glycaemic control in type 2 (drug treatments).Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness studyWhen glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT studyReview of biphasic insulin aspart in the treatment of type 1 and 2 diabetes.Diabetes medications and body weight.Biphasic insulin aspart in the treatment of type 2 diabetes mellitus.Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus.Effect of biphasic insulin aspart on glucose and lipid control in patients with Type 2 diabetes mellitus.Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.Improved glycaemic control with reduced hypoglycaemic episodes and without weight gain using long-term modern premixed insulins in type 2 diabetes.TREATMENT OF TYPE 2 DIABETES WITH BIPHASIC INSULIN ANALOGUES.
P2860
Q26784192-CD9EDF6C-725B-494D-B2D6-03C554BA7A45Q30832212-EF3107F9-FF09-43AE-9445-C77E1CEE36C3Q33476850-C115714A-C617-4B43-934F-FD0BAE68A911Q34829290-94D32752-064A-46A2-866F-488EC3D12BE5Q36045779-C6C138DB-CE5B-4375-9BF2-BD4C6CE3590DQ36735575-8A623BB3-3590-4695-B3EC-85E6879436D8Q37058917-A08DFB5E-AB62-47EC-90B1-226D005212D7Q37524006-BC54E3CA-589A-44FC-A55F-C0D7AE84BBDDQ37636162-96C4BAEC-659A-4D30-834E-003DD8B28529Q38983622-C80EFBA9-7F85-4DAE-84E8-B731705852C6Q42636940-C823B512-54B3-415A-B161-85B46D92E74DQ46758021-CCC849D8-6049-49A3-B438-A6A550B19BC0Q47400451-653BBFEB-1E82-4079-9B19-8D51B3EB3432Q51275520-0D409110-F561-429D-972E-273818452017
P2860
Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Biphasic insulin aspart 30: li ...... nts associated with treatment.
@ast
Biphasic insulin aspart 30: li ...... nts associated with treatment.
@en
type
label
Biphasic insulin aspart 30: li ...... nts associated with treatment.
@ast
Biphasic insulin aspart 30: li ...... nts associated with treatment.
@en
prefLabel
Biphasic insulin aspart 30: li ...... nts associated with treatment.
@ast
Biphasic insulin aspart 30: li ...... nts associated with treatment.
@en
P2093
P1476
Biphasic insulin aspart 30: li ...... nts associated with treatment.
@en
P2093
Domenico Cucinotta
Jaime Davidson
Julius Vaz
Patrick Vexiau
Ryuzo Kawamori
P304
P356
10.1016/J.CLINTHERA.2005.11.022
P478
27 Suppl B
P577
2005-01-01T00:00:00Z